Fertility preservation in Hyderabad may be considered for medical reasons or because someone wants to preserve reproductive options for the future. The available methods are not interchangeable. Egg freezing, embryo freezing and ovarian tissue cryopreservation differ in timing, procedures, future use and the type of patient for whom they are suitable.

Egg freezing

Oocyte cryopreservation involves ovarian stimulation, egg retrieval and vitrification of mature eggs. It allows future decisions about sperm source and embryo creation. Age at freezing and the number of oocytes stored influence future potential, but no number guarantees a live birth.

Embryo freezing

Embryo cryopreservation involves fertilising eggs before freezing embryos. It may be appropriate when sperm source and consent decisions are already established. Future use is governed by medical, consent and legal requirements.

Ovarian tissue cryopreservation

Ovarian tissue cryopreservation involves removing and freezing ovarian cortical tissue. ASRM recognises it as a fertility-preservation option for selected patients, especially where medical treatment threatens ovarian function and time or age makes conventional stimulation difficult. It requires specialist counselling about indications, surgical procedure, future use and limitations.

Medical fertility preservation

Cancer therapies and some other gonadotoxic treatments can reduce fertility. ASRM’s 2026 guidance emphasises discussing preservation before treatment where feasible, while coordinating with the treating medical team so cancer or other urgent care is not unnecessarily delayed.

Planned fertility preservation

Some people consider planned egg freezing because they are not ready to conceive. Counselling should explain that fertility naturally changes with age and that freezing eggs preserves the age of the eggs at retrieval, not the person’s future pregnancy health.

Questions to ask before deciding

Ask which option fits your reason for preservation, how urgent treatment is, how many cycles might be considered, what storage involves, who controls future use, and what current data can and cannot predict. See MotherToBe’s overview of fertility preservation in Hyderabad for available services.

Build a preservation timeline

If fertility preservation is being considered before medical treatment, write down the planned treatment start date and ask how quickly reproductive procedures can be organised. If preservation is planned for personal reasons, think about age, family-building goals and whether one or more stimulation cycles are financially and emotionally realistic.

Storage is part of treatment, not an afterthought

Ask where eggs, embryos or tissue are stored, how specimens are identified, what happens during power or equipment failure, how annual fees are handled, and how consent changes are recorded. Cryostorage quality and governance matter because the material may remain stored for years.

Fertility Preservation Expertise: Dr. S. Vyjayanthi

At MotherToBe Fertility Clinic & Academy, Madhapur, Hyderabad, fertility care is led by Dr. S. Vyjayanthi, MD, DGO, DNB, MRCOG, MSc (Embryology, UK), CCT (UK), a Subspecialist in Reproductive Medicine & Surgery (RCOG, UK). She serves as Director & Consultant Fertility Specialist at MotherToBe.

Her professional leadership roles include President, Telangana Chapter RCOG; Managing Committee Member, The PCOS Society of India; and Managing Committee Member, Fertility Preservation Society of India.

Her Managing Committee role with the Fertility Preservation Society of India, along with training in reproductive medicine and embryology, is particularly relevant to counselling on egg, embryo and ovarian tissue preservation options.

Read more about Dr. S. Vyjayanthi’s qualifications, leadership roles and Director’s Message on the MotherToBe website.

Frequently Asked Questions

Is fertility preservation only for cancer patients?

No. It may be considered for medical indications and, in some situations, planned future fertility.

Which is better: eggs or embryos?

Neither is universally better. The choice depends on circumstances, sperm source, consent preferences and treatment goals.

Can ovarian tissue be frozen without ovarian stimulation?

Yes, ovarian tissue cryopreservation does not require the same stimulation cycle as egg freezing, but it is used for selected indications.

Should fertility preservation delay medical treatment?

Coordination with the primary medical team is essential. Some preservation options can be completed quickly, but the priority and timing depend on the underlying condition.

Key takeaways

  • Choose treatment or a specialist based on diagnosis, evidence, transparency and individual needs—not on unverified ‘best’ or ‘top’ claims.
  • Use the target keyword naturally in the title, introduction and relevant context. Do not repeat it mechanically throughout the article.
  • Link this article to the relevant MotherToBe service page and link back from related educational content where it genuinely helps the reader.
  • Have the medical content reviewed before publication and update it when important clinical guidance changes.

Suggested internal links

Primary service link: fertility preservation in Hyderabad

Doctor profile link: Dr. S. Vyjayanthi – Director’s Message

Also add 2–4 natural internal links to closely related MotherToBe guides where relevant. Vary anchor text and avoid sitewide exact-match repetition.

Medical review and publishing note

Educational content only. Before publication, a qualified fertility specialist should verify the medical statements, local legal/regulatory details, clinic-specific services, doctor credentials and any costs or outcome data. Add the reviewer name, credentials and review date only after a real review. Proposed medical reviewer: Dr. S. Vyjayanthi; publish only after her review and approval of the clinical wording.

References for medical review

  • ASRM: Fertility Preservation in Patients with Medical Indications (2026)
  • ASRM: Fertility Preservation and Reproduction in Patients Facing Gonadotoxic Therapies (2026)
  • ASRM: Planned Oocyte Cryopreservation (2023)